P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS Read more about P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS European Patent96903473.5Filed on 1996-01-11
P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS Read more about P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS Canada2209990Filed on 1996-01-10
P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS Read more about P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS Australia47554/96Filed on 1996-01-11
DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF Read more about DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF European Patent95927269.1Filed on 1995-07-19
2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME Read more about 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME European Patent95942621.4Filed on 1995-12-19
2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME Read more about 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME Australia43786/96Filed on 1995-12-19
TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS Read more about TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS Canada2206205Filed on 1997-05-27
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK Read more about USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK Japan517097/1996Filed on 1995-11-20
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK Read more about USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK European Patent95940844.4Filed on 1995-11-20
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK Read more about USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK Canada2205555Filed on 1997-05-20